SSRIs boosted the ability of T cells to kill cancer cells and suppressed tumor growth in both mouse and human tumor models.

The antibody PLT012 targets the fat transporter CD36 to restore immune responses in tumors, offering a new and promising ...

The field of tumor immunology has highlighted the adeptness of tumor cells in evading the host's immune system. This insight has fueled interest in ...

A pair of recent studies from the laboratory of Bin Zhang, MD, Ph.D., the Johanna Dobe Professor of Cancer Immunology, have ...

Researchers say, “It turns out SSRIs don’t just make our brains happier; they also make our T cells happier—even while ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Understanding the interplay between immune cells and targeted cancer therapies is crucial for advancing oncological treatments. While targeted therapies ...

Former US President Joe Biden diagnosed with prostate cancer, a common cancer in men, with various treatment options ...